NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Wuxi Dexter Bio-tech Co., Ltd.

Wuxi Dexter Bio-tech Co., Ltd.

Private
WuxiConsumer & Commercehttps://www.brandstar.com.cn/

Last Round

Series B

Extension

Jun 4, 2021

Total Funding Raised

$9.46M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Wuxi Dexter Bio-tech Co., Ltd. is a consumer goods company that specializes in the research, development, and marketing of baby and child-specific skincare products.

Sector

Consumer & Commerce

Verticals

D2C Brands, Fashion & Beauty, Social Commerce

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

baby skincarechildren's toiletriessensitive skin carehypoallergenic skincarebaby sunscreenD2C brandsocial commerceclean beautynatural baby productseczema reliefmom and babyscience-backed skincare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wuxi Dexter Bio-tech Co., Ltd. Comparables

Compare Wuxi Dexter Bio-tech Co., Ltd. with similar companies based on industry and business-model similarity.

Wuxi Dexter Bio-tech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hi!Papa
86%
Zhejiang Yunting Biotechnology Co., Ltd.
83%
Evereden
78%

Wuxi Dexter Bio-tech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJun 4, 2021
Series BDec 8, 2020
Series A ExtensionJun 1, 2020
Series AMar 1, 2020

Key People

Founding team and executive leadership

Brian Lai

Founder&CEO

Founding Team

Wuxi Dexter Bio-tech Co., Ltd. Investors

Notable investors and investment history

Wuxi Dexter Bio-tech Co., Ltd. investors
InvestorRounds
Jinding CapitalSeries B Extension
Vertex Ventures ChinaSeries B Extension, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 34% MoM.

  • Dec 8, 2020

    Raised Series B round led by Vertex Ventures China.

Wuxi Dexter Bio-tech Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Wuxi Dexter Bio-tech Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wuxi Dexter Bio-tech Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersWuxi
Employee Range14
Year Founded2017
Last FundingJun 4, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.